The role of human papillomavirus testing in cervical screening
- 31 March 2005
- journal article
- review article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 32, 34-42
- https://doi.org/10.1016/j.jcv.2004.11.020
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Type‐specific associations of human papillomavirus load with risk of developing cervical carcinoma in situInternational Journal of Cancer, 2004
- The cervical cancer epidemic that screening has prevented in the UKThe Lancet, 2004
- Virologic Versus Cytologic Triage of Women With Equivocal Pap Smears: A Meta-analysis of the Accuracy To Detect High-Grade Intraepithelial NeoplasiaJNCI Journal of the National Cancer Institute, 2004
- Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for ScreeningObstetrics & Gynecology, 2004
- Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significanceAmerican Journal of Obstetrics and Gynecology, 2003
- A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretationsAmerican Journal of Obstetrics and Gynecology, 2003
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Age-restricted cervical screening: HPV testing at age 50 identifies a high risk group for cervical diseaseInternational Journal of Gynecologic Cancer, 2002
- Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real‐time polymerase chain reaction analysisCancer, 2002
- Natural History of Cervical Intraepithelial NeoplasiaInternational Journal of Gynecological Pathology, 1993